Clinical Trial Update: Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ARINA-1 to prevent progression of bronchiolitis obliterans syndrome in participants with bilateral lung transplants; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome

Drugs mentioned

• ARINA-1

Snippet

Sponsor: Renovion, Inc. | Conditions: Pre-Bronchiolitis Obliterans Syndrome | Phase 3 | Status: RECRUITING